Granulocyte macrophage colony stimulating factor (GM-CSF) current status and future development.
Bonnem
E M
EM
Clinical Research Division, Schering Corporation, Kenilworth, NJ 07033.
Morstyn
G
G
D000818:Animals; D002455:Cell Division; D055598:Chemical Phenomena; D002621:Chemistry; D003115:Colony-Stimulating Factors / Q000494:pharmacology / Q000627:therapeutic use*; D005544:Forecasting; D016178:Granulocyte-Macrophage Colony-Stimulating Factor; D006098:Granulocytes / Q000166:cytology; D006133:Growth Substances / Q000494:pharmacology / Q000627:therapeutic use*; D006402:Hematologic Diseases / Q000628:therapy; D006801:Humans; D007970:Leukopenia / Q000209:etiology / Q000628:therapy; D008264:Macrophages / Q000166:cytology; D009504:Neutrophils / Q000502:physiology; D011994:Recombinant Proteins / Q000627:therapeutic use
D003115:Colony-Stimulating Factors; D006133:Growth Substances; D011994:Recombinant Proteins; D016178:Granulocyte-Macrophage Colony-Stimulating Factor